UBS Group
TLSIW icon

UBS Group’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

UBS Group’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-49
Closed -$4 – 10372
2022
Q4 		$4 Sell
49
-4,480
-99% -$304 ﹤0.01% 10620
2022
Q3 		$0 Sell
4,529
-10
-0.2% -$1 ﹤0.01% 10925
2022
Q2 		$0 Hold
4,539
– – ﹤0.01% 10943
2022
Q1 		$1K Sell
4,539
-525
-10% -$226 ﹤0.01% 9931
2021
Q4 		$3K Sell
5,064
-942
-16% -$865 ﹤0.01% 9695
2021
Q3 		$5K Buy
+6,006
New +$5.57K ﹤0.01% 8559
2021
Q2 		– Sell
-148
Closed – – 9823
2021
Q1 		$0 Buy
+148
New +$267 ﹤0.01% 9466

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

UBS Group's TLSIW Position: Q1 2023 in Review

UBS Group sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2023, closing a stake of 49 shares — an estimated $4 sold.

UBS Group first reported a position in TLSIW in Q1 2021 and held it in 7 quarters. The position peaked at $5K in Q3 2021. 24 funds tracked by Wall St. Rank hold TLSIW as of Q1 2023.

  • UBS Group reported no remaining TriSalus Life Sciences Warrant position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 49 TriSalus Life Sciences Warrant shares in Q1 2023, an estimated $4.
  • UBS Group first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 7 quarters.
  • UBS Group's TriSalus Life Sciences Warrant position peaked at $5K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.